LACTOSE (INDIA)
Back to Income Statement
|
LACTOSE (INDIA) Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹116 Cr | ₹114 Cr | ₹66 Cr | ₹46 Cr | ₹35 Cr |
What is the latest Revenue of LACTOSE (INDIA) ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹116 Cr |
| Mar2024 | ₹114 Cr |
| Mar2023 | ₹66 Cr |
| Mar2022 | ₹46 Cr |
| Mar2021 | ₹35 Cr |
How is Revenue of LACTOSE (INDIA) Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹116 Cr | 2.20 | |
| Mar2024 | ₹114 Cr | 73.10 | |
| Mar2023 | ₹66 Cr | 43.22 | |
| Mar2022 | ₹46 Cr | 31.39 | |
| Mar2021 | ₹35 Cr | - | |
Compare Revenue of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹124.6 Cr | -2.4% | -4.8% | -2.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,990.0 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | -2.4% |
-4.8% |
-2.4% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses